Tolvaptan in Japanese patients with later-stage autosomal dominant polycystic kidney disease.

CONCLUSION: This analysis indicates that the efficacy of tolvaptan for Japanese patients with later stage ADPKD was not significantly different from that of Japanese patients with earlier stage ADPKD.
PMID: 30357715 [PubMed - as supplied by publisher]

Source: Journal of Nephrology - October 24, 2018 Category: Urology & Nephrology Authors: Oguro M, Kogure Y, Hoshino J, Ubara Y, Mizuno H, Sekine A, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Takaichi K Tags: J Nephrol Source Type: research